A phase IV, multicentre, open-label study of emicizumab prophylaxis in people with haemophilia A with or without FVIII inhibitors undergoing minor surgical procedures.

ABSTRACT:

SUBMITTER: Escobar M 

PROVIDER: S-EPMC9544354 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature